scholarly journals Assessment of β-Aescin Effect in Streptozotocin Induced Diabetic Model: Diabetic Hepatotoxicity Study

Author(s):  
Saumya Gupta ◽  
Megha Tiwari ◽  
Vishal Dubey

Objective - Diabetic hepatotoxicity involves complex events which include kupffer cell activation, formation of reactive oxygen species, cytokines release (TNF-α, IL-1β), and finally leads to hepatocyte death. “β- Aescin showed anti-inflammatory, anti-oxidant, gastroprotective and anti-oedema properties. The present study investigated the protective effect of β- Aescin in streptozotocin induced diabetic hepatotoxicity. Method - Female mice were divided into six groups, the first group served as the control, the second to sixth group received single i.p. dose of 90 mg/kg of STZ, the second group served as the untreated diabetic group, the third, fourth and fifth group received β- aescin intra-peritoneally at the dose of 0.9 mg/kg, 1.8 mg/kg and 3.6 mg/kg body weight respectively. The last sixth group was treated with 10 mg/kg glibenclamide i.p. for 14 days. A significant decrease in the blood glucose level was showed in β-aescin group as compared to the control group. Result - A significant increase of blood glucose level was observed in high and mid dose of β- aescin (3.6 mg/kg and 1.8 mg/kg respectively), standard drug (glibenclamide 10 mg/kg) groups as compared to control group. ROS generation was evaluated by using DCF-DA estimation method for the acute toxicity in liver tissue. Streptozotocin group showed more ROS generation in comparison to β- aescin group (3.6 mg/kg). Serum biochemical markers showed a significant decrease in β- aescin treated diabetic mice compared to untreated diabetic mice. Histopathological evaluation showed severe changes in untreated diabetic liver tissue marked by large number of inflammatory cells such as lymphocytes along with hepatic sinusoidal inflammation and hepatocyte necrosis whereas treated diabetic mice with β- aescin showed reduction in hepatotoxicity marked by regeneration changes of hepatocytes and mildly hepatocyte degeneration. Conclusion - In the study, β- aescin showed beneficial effects on the efficient properties of the liver and microscopic improvements in diabetic hepatotoxicity.

Pro Food ◽  
2020 ◽  
Vol 6 (1) ◽  
pp. 581
Author(s):  
Imam Adriansyah ◽  
Dody Handito ◽  
Rucitra Widyasari

ABSTRACT The aim of this present study was to determine the effectiveness of fucntional Robusta coffee powder fortified by Muntingia calabura L. leaves to lower blood glucose level in diabetic mice according to the antioxidant activity and total phenolic content, and the effectivness of the chosen ratio of the antidiabetic functional coffee beverage to the body weight and blood glucose level in diabetic mice. This research was conducted in two stages. First, determining the best ratio of the antidiabetic functional coffee beverage using randomized complete design. Second, testing the best ratio to the speciment using the randomized post test-only control group design to perform the chosen ratio of the antidiabetic functional coffee beverage to diabetic mice in seven days treatment. The results showed that the best ratio of the antidiabetic functional coffee beverage was 25% robusta coffee powder and 75% Muntingia calabura L. leaves powder with 88.26% antioxidant activity and 1.05 mg GAE/g sample, and the chosen ratio of the antidiabetic functional coffee beverage proved the activity to reduce the blood glucose level in diabetic mice with the decrease level was 266 mg/dl or 45% effective to reduced the blood glucose level in diabetic mice. This blood glucose reduced activity was not significant to the positive control group given glibenclamid, but it was found significant to the negative control group that given aquades per oral. While the body weight of the diabetic mice given aquades only decreased twice higher than positive control group and antidiabetic functional coffee beverage group. Keywords: blood glucose level, diabetic, Muntingia calabura L. leaves, robusta coffee   ABSTRAK Tujuan dari penelitian ini adalah untuk menentukan rasio terbaik antara bubuk kopi robusta dan bubuk daun kersen sebagai minuman fungsional yang difortifikasi bubuk daun kersen terhadap penurunan kadar gula darah mencit diabetes, yang ditinjau dari aktivitas antioksidan dan kadar fenolik total, serta pengaruh rasio terpilih terhadap berat badan dan penurunan kadar gula darah mencit diabetes. Penelitian ini dilakukan dalam dua tahap, yang pertama yaitu penentuan rasio terbaik antara bubuk kopi robusta dan bubuk daun kersen menggunakan metode rancangan acak lengkap (RAL) dengan faktor tunggal berupa rasio bubuk kopi robusta dan bubuk daun kersen. Kedua, yaitu pengujian rasio terbaik pada hewan percobaan menggunakan metode rancangan acak dengan tes akhir dan kelompok kontrol dengan parameter kadar gula darah dan berat badan mencit selama tujuh hari perlakuan. Hasil dari penelitian ini adalah rasio terbaik dari kopi fungsional antidiabetes diperoleh dari rasio 25% bubuk kopi robusta dan 75% bubuk daun kersen dengan aktivitas antioksidan sebesar 88,26% dan kadar fenolik total sebesar 1,05 mg GAE/g bahan. Berdasarkan uji in vivo, produk kopi fungsional antidiabetes mampu menurunkan kadar gula darah mencit diabetes sebesar 266 mg/dl atau sekitar 45%, tidak berbeda nyata dengan perlakuan kontrol positif yang diberikan obat glibenklamid dengan penurunan sebesar 268 mg/dl atau sekitar 47%, namun berbeda nyata dengan kelompok perlakuan kontrol negaif menggunakan aquades yang mengalami peningkatan kadar gula darah sebsar 4,2%. Sedangkan untuk parameter berat badan, bahwa penurunan berat badan mencit kelompok perlakuan kontrol negatif menggunakan aquades mengalami penurunan dua kali lebih besar dibandingkan kelompok kontrol positif dan kelompok produk kopi fungsional. Kata kunci: daun kersen, diabetes, kadar gula darah, kopi robusta


2020 ◽  
Author(s):  
Shahrear Biozid ◽  
Mohammad Nazmul Alam ◽  
Jainul Abeden ◽  
Faruk ◽  
Ahmad Ibtehaz Chowdhury ◽  
...  

Objective: To evaluate the anti-diabetic and anti-diarrheal activity of methanol extract of Flemingia stricta Roxb. (Fabaceae) leaf.Methods: In anti-diabetic study, the extract was administered to alloxan-induce diabetic mice at two concentrations (200mg/kg and 400mg/kg body weight) for acute (12 hours) and prolong treatments (15 days) and blood glucose levels (Blood glucose level) of diabetic mice were monitored at intervals of hours and days throughout the duration of treatment. Antidiarrheal test was conducted by castor oil induced diarrhea and enteropooling as well as intestinal motility in mice at three different concentration (100mg/kg, 200mg/kg and 400mg/kg body weight).Results: Treatment of alloxan induce diabetic mice with the extract caused a significant reduction in fasting blood glucose level of the diabetic mice both in acute (12 hours) and prolong treatment (15 days) and it was determined that the extract at both concentration (200mg/kg and 400mg/kg) showed the significant (P<0.05) hypoglycemic effect in comparison to the standard drug Metformin (10mg/kg). In the case of castor oil induced diarrheal test, enteropooling test and gastrointestinal motility test, the extract of F. stricta at 100mg/kg, 200mg/kg and 400mg/kg has given significant effect (P<0.05) in comparing to standard drug Loperamide (5mg/kg). Conclusion: These result suggested that the methanol extract of F. stricta Roxb. possess promising anti-diabetic effect on alloxan-induced mice and significant antidiarrheal effect on castor oil induced diarrheal mice.


Food Research ◽  
2020 ◽  
Vol 5 (1) ◽  
pp. 72-77
Author(s):  
S. Bashir ◽  
S.A. Raza ◽  
M. Ahmad ◽  
M. Farhan ◽  
S. Ali ◽  
...  

The Parthenium hysterophorus (P. hysterophorus) is used to treat diabetes mellitus in local medicinal system of Pakistan but very limited scientifically proved information is available in this context. The objective of this work was to evaluate the antioxidant and antidiabetic activity of P. hysterophorus leaf extract. The extraction was made with freeze drying assisted ultrasonication using 40%, 60% and 80% ethanol as solvent. The total phenolic and flavonoid contents were calculated. Antioxidant activity was determined by 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay and α-glucosidase inhibitory assay was also performed. The in vivo hypoglycemic potential of leaf extract was determined in alloxan monohydrate induced diabetic mice. The 60% ethanolic extract exhibited comparatively higher phenolic and flavonoid contents with values of 105.44±2.55 mg GAE/g D.E and 41.50±2.25 mg RE/g D.E, respectively. The 60% extract also possessed lowest IC50 value of 87.55 μg/mL and 98.22 μg/mL for DPPH radical scavenging and α-glucosidase inhibition, respectively. The same extract substantially reduced the blood glucose level in alloxan induced diabetic mice and results were quite comparable with standard drug metformin. The extract dose of 450 mg/kg reduced the blood glucose level of diabetic mice from 268.05 mg/dL 137.88 mg/dL at the end of 28 days treatment. The findings confirmed the ethnopharmacological use of P. hysterophorus to treat and manage diabetes mellitus type 2. The experimental outcomes may be employed as pharmacological leads to treat diabetes mellitus and to develop functional foods with hypoglycemic attributes.


2020 ◽  
Vol 11 (4) ◽  
pp. 5067-5070
Author(s):  
Pang Jyh Chayng ◽  
Nurul Ain ◽  
Kaswandi Md Ambia ◽  
Rahim Md Noah

The purpose of this project is to study the anti-diabetic effect of on a diabetic rat model. A total of Twenty male Sprague rats were used and it randomly distributed into four groups which are Group I: , Group II: negative control, Group III: and Group IV: and . In diabetic model were induced with via injection at the dosage of 65mg/kg. and FBG (Fasting Blood Glucose) level of diabetic rats were assessed every three days. Blood was collected via cardiac puncture at day 21 after the induction of treatment. Insulin level of the rats was assessed with the Mercodia Rat Insulin ELISA kit. FBG level of group I (12.16 ±3.96, p<0.05) and group IV (11.34 ±3.67, p<0.05) were significantly decreased. Meanwhile, the for all rats did not show any significant increase. However, the insulin level was escalated in group IV (0.74+0.25, p<0.05) significantly. The present study shows that the and the combination of and lowered blood glucose level and enhanced insulin secretion.


2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Mrs. Vanitha. S s ◽  
Dr. Pramjit kaur

Challenges in lifestyle, such as increasesin energy intake and decreasesin physical activity are causing overweight and obesity leading to epidemic increases in type II Diabetes Mellitus. The research approach used for this study was evaluative approach and the research design was true experimental design. 60 patients with type II diabetes, 30 in experimental group and 30 in control group were selected for this study by using purposive sampling technique. Data was collected with the help of self-structured interview schedule. Descriptive statistics (frequency, percentage, mean and standard deviation) and inferential statistics (chi-square, paired ‘t’ test) were used to analyse the data and to test the hypotheses. In the experimental group,the pre-test mean score was 2.966, mean percentage was 59% and standard deviation was 1.129 and in post-testmean score was 2.533, mean percentage was 50.66% and standard deviation was 1.074 with effectiveness of 8.34% and paired‘t’ test value of t=3.971,which was statistically significant (p<0.05) which is an evidence ofthe effectiveness of Amla juice in reducing blood glucose level. Comparison of blood glucose levels in experimental and control groups, shows that the value is statistically highly significant, as was observed from the unpaired ‘t’ test value of 13.39 with P value of <0.05, which is an evidence indicatingthe effect of Amla juice in reducing postprandial blood glucose levels. The resultsfound that the administration of Amla juice did have aneffect in reducing blood glucose level in the experimental group. By comparing the findings of pre-test and post test between the experimental group and the control group,the effect was identified (assessed). The study concluded that the Amlajuice is effective in reducing blood glucose level.


Author(s):  
Pooja Pooja ◽  
Mazumder Avijit ◽  
Soumya Das

Diabetes is a chronic disease which characterized by hyperglycemia (elevated or abnormally high blood sugar levels) and other metabolic disturbances, including metabolism of lipids and haemostasis. Caesalpinia pulcherrima has previously showed strong anti-diabetic and hepatoprotective potential. The present research work was to investigate the anti-diabetic activity and hepatoprotective activity Caesalpinia pulcherrima in streptozotocin-induced (STZ) diabetic rats. The dose-dependent effects of 45days oral treatment with methanol extract of plant (200 and 300mg/kg) of CPAE on body weight, blood glucose level, total protein, albumin, liver marker enzymes and carbohydrate metabolizing enzymes were evaluated in STZ-induced diabetic rats. Oral administration methanolic extract of Caesalpinia pulcherrima of showed significant restoration of the body weight and decrease in the blood glucose level, liver marker enzymes (ALT, AST ALP) and carbohydrate metabolizing enzymes were observed in diabetic rats. These results suggest that fruit extract of Caesalpinia pulcherrima has valuable anti-diabetic activity in STZ-induced diabetic rats which is comparable to the standard drug metformin and hence might be of use in the management of diabetes.


2021 ◽  
pp. 193-200
Author(s):  
Prasetyastuti Prasetyastuti ◽  
Dian Setiawan Ghozali

Diabetes Type 2 can cause oxidative stress leading to the accumulation of reactive oxygen species. Soyferment-Tempeh, a fermented soybean product with aerobic and anaerobic R. oligosporus incubation has a high antioxidant content of isoflavones that can regulate oxidative stress in diabetes. In this study, we evaluate the effects of Soyferment-Tempeh on lipid profile, Retinol-Binding Protein 4 (RBP4), and Phosphoenolpyruvate Carboxykinase (PEPCK) gene expression in type 2 diabetic mice. A total of 30 mice with the age of eight weeks were divided into six groups as follows: A) nondiabetic, B) diabetic mice, C) diabetic mice with metformin, D), E), and F) diabetic mice with Soyferment-Tempeh doses of 10, 20, or 40mg/100g body weight (BW), respectively, were administered treatments orally by gavages. Blood was collected for assessment of blood glucose level, and lipid profile before and after 3 weeks of the administration. After sacrificing the mice, livers were used for RBP4 and PEPCK gene expression assessment. Supplementation with three different doses of Soyferment-Tempeh in streptozotocin-induced diabetic mice for 21 days significantly (p<0.001) reduced blood glucose level, total cholesterol, triglycerides, low-density lipoprotein level, atherogenic index, and increased high-density lipoprotein level. There was a significant decrease in RBP4 gene expression in the Soyferment-Tempeh of dose 10mg/100g BW treatment groups (p<0.05), while the PEPCK gene expression did not significantly differ (p>0.05). These results demonstrate that supplementation with Soyferment-Tempeh decreases blood glucose level, atherogenic index, improves lipid profile, and decreases RBP4.


2020 ◽  
Vol 23 (2) ◽  
pp. 135-140
Author(s):  
Md Monirul Islam ◽  
Tufael Ahmed ◽  
Hajera Khatun ◽  
Mohammad A Rashid

The fruits of Stixis suaveolens (Roxb.) have been a popular folk medicine among traditional practitioners. However, there are questions about its traditional uses due to lack of scientific evidence. This study was aimed to evaluate the effects of crude methanol extract of fruits of S. suaveolens in mice model. The central and peripheral analgesic activity were evaluated using the ‘tail flick’ and ‘writhing’ assay respectively. The anti-hyperglycemic potential was assessed by the ability of the crude extract in reducing blood glucose level in mice after oral administration of glucose. Oral administration (400 mg/kg bw) of the extract showed significant (p<0.001) delay in pain sensation and inhibition of acetic acid induced writhing response in mice model. The results were compared with the respective standard morphine (2 mg/kg bw) and diclofenac (50 mg/kg bw). Likewise, in anti-hyperglycemic assay, maximum reduction (p<0.001) of blood glucose level (39.6%) was observed 120 min after oral intake (400 mg/kg bw) of the extract as compared that exhibited by the standard drug, glibenclamide (46.83%). The in vivo bioassays confirmed that the crude methanolic extract of fruits of S. suaveolens possesses significant central- and peripheral-analgesic as well as anti-hyperglycemic activities. These findings justify its popularity as a traditional medicine and hence demands future study involving isolation and characterization of its bioactive compounds. Bangladesh Pharmaceutical Journal 23(2): 135-140, 2020


Sign in / Sign up

Export Citation Format

Share Document